← Back to all trials
Completed
NCT07879833
AI-Personalized Skincare Regimen for Facial Photoaging in Women
Conditions: Photoaging, Skin Aging
Sex: Female
Ages: 35 Years – 65 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 43
Sponsor: MDalgorithms Inc.
Location: SGS North America Inc., Clinical Research Richardson Texas
Summary
The goal of this clinical study was to learn whether a skincare regimen personalized by an artificial intelligence (AI) skin-analysis tool improves signs of facial skin aging in women aged 35 to 65 with mild-to-moderate facial photoaging. The main questions it aimed to answer were: Does the personalized regimen improve fine lines, wrinkles, firmness, smoothness, tone and other signs of skin aging after 4 and 12 weeks of use? Is the regimen well tolerated? Participants completed an online skin questionnaire and uploaded a facial selfie, and the AI tool assigned one of three night creams. Each participant then used a personalized kit at home for 12 weeks: a vitamin C serum and SPF 30 sunscreen in the morning; the assigned night cream (0.3% retinol, 0.6% retinol, or bakuchiol, each with a triple-peptide complex), an eye cream, and a dark spot remover in the evening; and a daily oral marine collagen supplement. Participants visited the clinic at baseline, week 4 and week 12 for expert skin grading, skin measurements, photographs and questionnaires.
Eligibility Criteria
Inclusion Criteria:
\-
Inclusion Criteria:
* Female, aged 35 to 65 years
* Fitzpatrick skin phototype II to VI
* Mild-to-moderate facial photoaging
* Willing to complete a 2-week washout from anti-aging products before baseline
* Able to provide written informed consent
Exclusion Criteria:
* Active facial dermatoses
* Use of prescription retinoids within 6 months before enrollment
* Cosmetic facial procedures within 3 months (injectables within 12 months) before enrollment
* Known allergy to any study product ingredient
Exclusion Criteria:
\-
Source: ClinicalTrials.gov (NCT07879833). StuddyBuddy aggregates publicly available trial information.